A single dose of a chromium-enriched glucomannan-fructo-oligosaccharide fiber complex significantly reduced postprandial ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.

We have five products that will launch in the next 12-18 months. We recently launched Yesintek in the immunology space -- a ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Explore our Reviews for real insights on this plant-based blood sugar supplement ingredients, and where to buy safely.

This human insulin analogue that comes in disposable pens prefilled with 1, 1.5, or 3 mL, dosed in 10-unit increments1 binds reversibly to albumin, which extends its half-life to around 7 days. Steady ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

The next wave, insulin analogs, began emerging in the mid-1990s. An insulin analog begins with genetically engineered human insulin, which is then modified to more closely resemble insulin ...

A study has found that two shots of insulin (basal insulin analog), though higher in dose, is marginally better than a single shot (premixed insulin) in lowering HbA1c (glycated haemoglobin).

Credit: Getty Images. Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death.

Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death. Treatment with analog rather ...

So, armed with the additional tailoring tools of genetic engineering, drug researchers began inventing insulin “analogs,” variations of the natural insulin protein, meant to supercharge performance.